Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

Apr 22, 2022

SELL
N/A
-1,689 Closed
0 $0
Q4 2021

Jan 28, 2022

SELL
N/A
-71 Reduced 4.03%
1,689 $0
Q3 2021

Oct 26, 2021

BUY
N/A
231 Added 15.11%
1,760 $0
Q2 2021

Jul 28, 2021

SELL
N/A
-81 Reduced 5.03%
1,529 $0
Q1 2021

Apr 30, 2021

SELL
N/A
-5,215 Reduced 76.41%
1,610 $0
Q4 2020

Jan 27, 2021

SELL
N/A
-2,424 Reduced 26.21%
6,825 $0
Q3 2020

Oct 06, 2020

BUY
N/A
601 Added 6.95%
9,249 $0
Q2 2020

Jul 10, 2020

BUY
N/A
4,494 Added 108.18%
8,648 $0
Q1 2020

Apr 17, 2020

SELL
N/A
-2,886 Reduced 40.99%
4,154 $0
Q4 2019

Jan 22, 2020

BUY
N/A
4,055 Added 135.85%
7,040 $0
Q3 2019

Oct 15, 2019

BUY
N/A
2,971 Added 21221.43%
2,985 $0
Q3 2018

Oct 24, 2018

BUY
N/A
13 Added 1300.0%
14 $0
Q4 2017

Jan 29, 2018

SELL
N/A
-10,503 Reduced 99.99%
1 $0
Q3 2017

Oct 18, 2017

BUY
N/A
10,504
10,504 $0

Others Institutions Holding CONE

# of Institutions
1
Shares Held
35
Call Options Held
0
Put Options Held
0

About CyrusOne Inc.


  • Ticker CONE
  • Sector Real Estate
  • Industry REIT—Specialty
  • Shares Outstandng 131,149,000
  • Market Cap $11.9B
More about CONE
Track This Portfolio

Track Exane Derivatives Portfolio

Follow Exane Derivatives and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Exane Derivatives, based on Form 13F filings with the SEC.

News

Stay updated on Exane Derivatives with notifications on news.